CD99 (p30/32(MIC2)) immunoreactivity in the diagnosis of leukemia cutis

Modern Pathology

Volumn 10, Issue 4, 1997, Pages 283-288

  Dorfman, David M ^a,c   Kraus, Madeleine ^a,c,d   Perez Atayde, Antonio R ^b,c   Barnhill, Raymond L ^a,c   Pinkus, Geraldine S ^a,c   Granter, Scott R ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

acute lymphoblastic leukemia; immunohistochemistry; lymphoblastic lymphoma; monoclonal antibody O13

Indexed keywords

CD99 ANTIGEN; UNCLASSIFIED DRUG; CD99 PROTEIN, HUMAN; CELL ADHESION MOLECULE; LEUKOCYTE ANTIGEN; TUMOR ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; LEUKEMIA; LYMPHOBLASTOMA; MALE; PRIORITY JOURNAL; SKIN CANCER; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; AGED; IMMUNOLOGY; IMMUNOPHENOTYPING; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; SKIN TUMOR;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOPHENOTYPING; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; LYMPHOMA, LYMPHOBLASTIC; MALE; MIDDLE AGED; SKIN NEOPLASMS;

EID: 0030610035     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. MIC2) neuroectodermal/Ewing's sarcoma antigen as an immunohistochemical marker. Appl Immunohistochem 1994;2:231-40.
2. Ambros IM, Ambros PF, Strehl S, Kovar H, Gadner H, Salzer-Kuntschik. MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Cancer 1991;67:1886-93.
3. MIC2. Am J Pathol 1991;139:317-25.
4. MIC2) immunoreactivity in the diagnosis of thymic neoplasms and mediastinal lymphoproliferative disorders: a study of paraffin sections using monoclonal antibody O13. Appl Immunohistochem 1996;4:34-42.
5. Riopel M, Dickman PS, Link MP, Perlman EJ. MIC2 analysis in pediatric lymphomas and leukemias. Hum Pathol 1994; 25:396-9.
6. Su WPD. Clinical, histopathologic, and immunohistochemical correlations in leukemia cutis. Semin Dermatol 1994;13: 223-30.
7. Pinkus GS, O'Hara CJ, Said JW. Peripheral/post-thymic T-cell lymphomas. A spectrum of disease: clinical, pathologic, and immunologic features of 78 cases. Cancer 1990;65:971-98.
8. Pinkus GS, Pinkus JL, Goldstein NS, Shintaku IP, Said JW. BLA36: a putative marker for B-cell proliferations. Staining profile of 426 paraffin-embedded tissues. Appl Immunohistochem 1995;3:23-31.
9. Meyers L, Hakami N. Pre-B-cell cutaneous lymphoma in infancy, a unique clinical entity. Med Pediatr Oncol 1984;12: 252-4.
10. Link MP, Roper M, Dorfman RF, Crist WM, Cooper MD, Levy R. Cutaneous lymphoblastic lymphoma with pre-B-cell markers. Blood 1983;61:838-41.
11. Vartanian RK, Sudilovsky D, Weidner N. Immunostaining of monoclonal antibody O13 [anti-MIC2 gene product (CD99)] in lymphomas. Appl Immunohistochem 1996;4:43-55.
12. Cooper K, Haffajee Z. Immunohistochemical assessment of MIC2 gene product in granulocytic sarcoma using six epitope retrieval systems. Appl Immunohistochem 1995;3: 198-201.
13. Orazi A, Cattoretti G, John K, Neiman RS. Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections. Mod Pathol 1994;7:582-6.